Home > Insider Trading > Filing (0001144204-14-002903)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1270073	Intercept Pharmaceuticals Inc	ICPT	Pharmaceutical Preparations (2834)	223868459

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1253170	Srinivas Akkaraju	C/O Intercept Pharmaceuticals, Inc. 450 W. 15Th Street, Suite 505 New York NY 10011		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-01-16	325	$0.00	2,693	No	4	M	Direct
Common Stock	Acquisiton	2014-01-16	2,500	$21.50	5,193	No	4	M	Direct
Common Stock	Disposition	2014-01-16	3,250	$267.94	1,943	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2014-01-16	325	$0.00	325	$0.00
Common Stock	Options to Purchase Common Stock	Disposition	2014-01-16	2,500	$0.00	2,500	$21.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
973			No	4	M	Direct
8,749		2022-11-18	No	4	M	Direct

Footnotes

The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 18, 2013.
Conversion of restricted stock units ("RSUs") to shares of common stock on a one-for-one basis.
On November 18, 2012, the reporting person was granted 2,596 RSUs. The RSUs reported as having been disposed and the corresponding shares reported as having been acquired, representing 12.5% of the shares originally underlying the RSUs, became vested on January 16, 2014, subject to the terms and conditions of the award and the Intercept Pharmaceuticals, Inc. 2012 Equity Incentive Plan (the "2012 Plan"). The remainder of the shares underlying the RSUs will vest pro rata on a quarterly basis from April 16, 2014 through October 16, 2014, subject to the terms and conditions of the award and the 2012 Plan.
This option to purchase common stock was originally granted to the reporting person on November 18, 2012 (original amount: 11,249 shares). 4.1667% of the shares underlying this option vested as of November 18, 2012, and the remainder of the shares underlying this option will vest pro rata on a monthly basis through October 16, 2014, subject to the terms and conditions of the award and the 2012 Plan.